SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: OmertaSoldier who wrote (21565)5/4/1999 8:56:00 AM
From: DaiS  Read Replies (1) | Respond to of 23519
 
OmertaSoldier,

...and we had this press released reported before on the two female SD studies when BigK was still posting....well what do they say 'if you have a good story...'

Vivus block buster press release coming any moment now, next few minutes IMO, I'm so exctied my hands are trembling.....

DaiS



To: OmertaSoldier who wrote (21565)5/4/1999 9:31:00 AM
From: Frostman  Respond to of 23519
 
<<Berman did a study with 17 women.>>

Yawn. So have most college freshmen. The placebo effect on this deal is probably in the 40% range, so the 10 remaining women, what was it, age 22 to 77, set the cutting edge base-line for Viagra's, uh, feminine side? Must have taken months to put together the population for this masterpiece. Sheesh!

Let's Rock n roll today!

Frostman


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News